Dayvigo 10 mg 100 tablets (Lemborexant)

Dayvigo 10 mg

Manufacturer: Eisai Co., Ltd. (Japan)
Generic name: Lemborexant
Dosage form: Tablets, 10 mg
Packaging: Box of 100 tablets (10 × 10 blisters)

Description

Dayvigo (Lemborexant) is an innovative sleep aid developed by Eisai for the treatment of insomnia.
It belongs to a new class of orexin receptor antagonists that help regulate the sleep-wake cycle naturally. Unlike traditional sedatives, Dayvigo promotes restful sleep without dependency or withdrawal symptoms.

Indications

• Insomnia (difficulty falling asleep or staying asleep).
• Sleep disturbances caused by overactivation of the nervous system.
• Chronic or transient sleep disorders.

Mechanism of Action

Lemborexant blocks orexin OX1 and OX2 receptors, reducing wakefulness signals in the brain.
This promotes faster sleep onset and better maintenance of deep, continuous sleep with minimal next-day drowsiness.

Benefits

• Non-habit forming and safe for long-term use.
• Supports natural sleep cycles.
• Reduces sleep latency and nighttime awakenings.
• Clinically proven efficacy and tolerability.

Composition

• Active ingredient: Lemborexant — 10 mg per tablet.
• Excipients: Lactose, microcrystalline cellulose, magnesium stearate, etc.

Dosage and Administration

Take orally once daily, immediately before bedtime.
The usual starting dose is 5 mg; may be increased to 10 mg as directed by a physician.

Contraindications

• Severe hepatic impairment.
• Sleep apnea (moderate or severe).
• Hypersensitivity to Lemborexant or any excipients.
• Not recommended during pregnancy or breastfeeding.

Side Effects

• Mild drowsiness, fatigue, headache.
• Occasionally — abnormal dreams or dizziness.
• Long-term use requires medical supervision.

Storage

Store below 25 °C, protected from light and moisture.
Keep out of reach of children.

Ask a question or inquire about delivery to your country

Telegram

WhatsApp